Hepatocellulcar Carcinoma Clinical Trials in Guangzhou, Guangdong
2 recruitingGuangzhou, Guangdong, China
Showing 1–2 of 2 trials
Recruiting
Phase 2
Efficacy and Safety Comparison Between Intensified Therapy and Conversion Therapy For Advanced HCC After Failure of First-line
Hepatocellulcar Carcinoma
Sun Yat-sen University80 enrolled1 locationNCT07501351
Recruiting
Phase 2
Dalpiciclib Plus Camrelizumab for HCC Patients Who Have Previously Received ICI Treatment
Hepatocellulcar Carcinoma
Sun Yat-sen University30 enrolled1 locationNCT07238881